General Information of This Metabolic Reaction (MR) (ID: MR001510)
Formula Reactant Levonorgestrel Product 3alpha, 5beta-tetrahydrolevonorgestrel
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001514 Levonorgestrel . Unclear Levonorgestrel [1]
MR001511 Levonorgestrel 16beta-hydroxylevonorgestrel Unclear Levonorgestrel [2]
MR001512 Levonorgestrel Glucuronide conjugates of levonorgestrel Conjugation - Glucuronidation Levonorgestrel [2]
MR001513 Levonorgestrel Sulfate conjugates of levonorgestrel Conjugation - Sulfation Levonorgestrel [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001508 3alpha, 5beta-tetrahydrolevonorgestrel 3alpha, 5beta-tetrahydrolevonorgestrel sulfate Conjugation - Sulfation Levonorgestrel [2]
References
1 [Influence of CYP3A4/5 polymorphisms in the pharmacokinetics of levonorgestrel: a pilot study]. Biomedica. 2012 Oct-Dec;32(4):570-7.
2 DrugBank(Pharmacology-Metabolism)Levonorgestrel

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.